Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × The Neoadjuvant Therapy × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

The Neoadjuvant Therapy 1 Neoplasms 1 Neoplasm Metastasis 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Cholangiocarcinoma 1 Breast Neoplasms 1

Interventions

Triptorelin Pamoate 1 Paclitaxel 1 Fulvestrant 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04753177 2021-02-15

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary

Phase 2/3 Unknown

The Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡